Alan Ezekowitz's Insider Trades & SAST Disclosures
Alan Ezekowitz's most recent trade in Septerna Inc. was a trade of 13,319 Common Stock done at an average price of $6.9 . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Alan Ezekowitz.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Septerna Inc. | Alan Ezekowitz | Director | Purchase of securities on an exchange or from another person at price $ 6.93 per share. | 07 Mar 2025 | 13,319 | 117,420 | - | 6.9 | 92,270 | Common Stock |
| Septerna Inc. | Alan Ezekowitz | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 04 Mar 2025 | 41,355 | 104,101 | - | 6 | 248,130 | Common Stock |
| Septerna Inc. | Alan Ezekowitz | Director | Purchase of securities on an exchange or from another person at price $ 5.82 per share. | 04 Mar 2025 | 37,835 | 62,746 | - | 5.8 | 220,260 | Common Stock |
| Septerna Inc. | Alan Ezekowitz | Director | Purchase of securities on an exchange or from another person at price $ 6.35 per share. | 04 Mar 2025 | 7,491 | 24,911 | - | 6.3 | 47,544 | Common Stock |
| Fulcrum Therapeutics Inc | Alan Ezekowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Organon & Co. | Alan Ezekowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 9,638 | 36,454 | - | - | Phantom Stock | |
| Fulcrum Therapeutics Inc | Alan Ezekowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Organon & Co. | Alan Ezekowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 10,086 | 25,285 | - | - | Phantom Stock | |
| Fulcrum Therapeutics Inc | Alan Ezekowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 19,000 | 19,000 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Alan Ezekowitz | Director | Other type of transaction at price $ 0.00 per share. | 27 Jun 2022 | 500 | 14,500 | - | - | Stock Option (right to buy) | |
| Organon & Co. | Alan Ezekowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 5,640 | 14,638 | - | - | Phantom Stock | |
| Fulcrum Therapeutics Inc | Alan Ezekowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Organon & Co. | Alan Ezekowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 8,772 | 8,772 | - | - | Phantom Stock | |
| Fulcrum Therapeutics Inc | Alan Ezekowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 9,285 | 9,285 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges